Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Longitudinal Study of the Effects of Subcutaneous Acute and Chronic Pasireotide (som230) Therapy on Adrenocorticotrophic Hormone and Tumour Volume in Patients With Nelson's Syndrome

NCT01617733 is registered in ClinicalTrials.gov with Sheffield Teaching Hospitals NHS Foundation Trust as lead sponsor.

NCT NCT01617733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01617733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Longitudinal Study of the Effects of Subcutaneous Acute and Chronic Pasireotide (som230) Therapy on Adrenocorticotrophic Hormone and Tumour Volume in Patients With Nelson's Syndrome
Lead sponsor
Sheffield Teaching Hospitals NHS Foundation Trust
Phase
Phase 2
Overall status
Terminated
Start date
March 31, 2011
Completion date
December 31, 2015
Enrollment
8 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

nelson syndrome